Pasteurized Eggs Corp. v. Bon Dente Joint Venture (In Re Pasteurized Eggs Corp.)

2003 BNH 13, 296 B.R. 283, 51 U.C.C. Rep. Serv. 2d (West) 274, 2003 Bankr. LEXIS 652, 2003 WL 21474218
CourtUnited States Bankruptcy Court, D. New Hampshire
DecidedMay 30, 2003
Docket19-10383
StatusPublished
Cited by3 cases

This text of 2003 BNH 13 (Pasteurized Eggs Corp. v. Bon Dente Joint Venture (In Re Pasteurized Eggs Corp.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pasteurized Eggs Corp. v. Bon Dente Joint Venture (In Re Pasteurized Eggs Corp.), 2003 BNH 13, 296 B.R. 283, 51 U.C.C. Rep. Serv. 2d (West) 274, 2003 Bankr. LEXIS 652, 2003 WL 21474218 (N.H. 2003).

Opinion

MEMORANDUM OPINION

J. MICHAEL DEASY, Bankruptcy Judge.

I. INTRODUCTION

The Debtor filed a complaint (Doc. No. 1) against Bon Dente Joint Venture (“BDJV”) seeking six declaratory judgments listed in three counts. Counts I and II seek a determination (i) that the patents and trademarks comprising Thermal-Pure™ Technology (the “Technology”), as defined in the Patent Purchase Agreement dated January 2, 1997 (the “Patent Purchase Agreement”) are property of the bankruptcy estate under section 541 of the Bankruptcy Code; 1 (ii) of the validity, priority and extent of BDJVs secured claim, if any; (iii) that the avoidance under section 544 of the Bankruptcy Code of any BDJV security interest which is unperfected; and (iv) that BDJVs right to future payments under the Patent Purchase Agreement constitutes a prepetition general unsecured claim. Count III seeks a determination that as of the petition date (i) no reversion of the Technology had occurred under the Patent Purchase Agreement and (ii) the Master Agreement negotiated in September 2001 had not become effective. BDJV filed an answer (Doc. No. 6) contesting all of the Debtor’s claims for declaratory relief and filing three counterclaims for (i) breach of the Patent Purchase Agreement, (ii) a declaratory judgment that the Master Agreement is valid and (iii) damages for interference with prospective business relations. The Debtor filed Debtor’s Motion for Partial Summary Judgment (Doc. No. 14) (the “Motion”) seeking summary judgment as to Counts I and II of its complaint. The Court held a hearing on March 25, 2003 and took the matter under submission.

This Court has jurisdiction of the subject matter and the parties pursuant to 28 U.S.C. §§ 1334 and 157(a) and the “Standing Order of Referral of Title 11 Proceedings to the United States Bankruptcy Court for the District of New Hampshire,” dated January 18, 1994 (DiClerico, C.J.). This is a core proceeding in accordance with 28 U.S.C. § 157(b).

II. FACTS

In January 2001, Pasteurized Eggs LP (“PELP”) and The Davidson Group Egg Shell Corporation (“Davidson Group”) were merged into a newly formed corporation, Pasteurized Eggs Corporation, the Debtor and Plaintiff in this proceeding. BDJV is the successor in interest to Dr. James P. Cox (“Dr. Cox”), R.W. Duffy Cox (“Duffy Cox”), Ramtek, Inc. and Bon Dente International. Dr. Cox and Duffy Cox obtained patents for the pasteurization of fresh in shell eggs known as the ThermalPure™ process and received one trademark for such technology (collectively the “Technology”). On January 2, 1997 Dr. Cox and Duffy Cox entered into an *286 agreement with the PELP and Davidson Group involving a transfer of rights to the Technology (the “Patent Purchase Agreement”). 2

The Patent Purchase Agreement recites that it was executed subsequent to the resolution of disputes under prior agreements between the parties involving the licensing, marketing and sublicensing of the Technology. Under section 2 of the Patent Purchase Agreement, BDJV agreed, subject to certain option conditions, “to transfer and assign to [the Debt- or] all of its respective rights, titles and interests” in the Technology, any future patents and improvements within the scope of the Technology, and any trademarks and associated goodwill. The option conditions in sections 4(a) through (c) conveyed to the Debtor the right to acquire the worldwide rights to the Technology by paying $1,465,000.03 in thirteen quarterly installments between the date of the agreement and October 1, 1999. Section 4(e) of the Patent Purchase Agreement provided that upon completion of the option payments “the Option shall be fully exercised and the assignments of all substantial patent and trademark rights for the ThermalPure™ Technology will become fully vested in [the Debtor] by operation of this Agreement.” After the completion of the option payments, sections 5 and 6 provide for the payment of certain royalty payments to BDJV over the term of the agreement. The term of the Patent Purchase Agreement is twenty years or until the last of the Technology rights expire, whichever is greater, unless terminated sooner under the terms of the agreement. Under section 10 of the Patent Purchase Agreement, BDJV has the right to terminate the agreement if any of the option payments or royalties are not paid within a specified time after written notice. The parties also agreed that upon termination of the Patent Purchase Agreement the Technology, including all improvements and trademarks would be transferred to BDJV by operation of the agreement and that such transfer was the sole remedy available to BDJV. During the term of the Patent Purchase Agreement, BDJV retained certain rights with respect to the Technology including:

1. the right to object to the Debtor’s choice of patent and trademark counsel, which objection could not be unreasonably asserted, and the right, at its own expense, to review and assist the Debtor in the prosecution of patent applications and litigation, so long as it does not unduly delay or interfere with the conduct of such matters by the Debtor’s counsel;
2. the right to file patent and trademark applications for rights accruable from the Technology that the Debtor determined that it did not desire to seek protection for; and
3. the right, at its own expense, to prosecute or defend any action for infringement or misappropriation of any patent, trademark or trade secret covered by the Patent Purchase Agreement if within six months of the statutory limits governing such actions the debtor determines not to undertake or to abandon such actions.

*287 There is no material dispute that the Debtor made all of the Option payments required under section 4 of the Patent Purchase Agreement. 3 Likewise, there is no material dispute that the Debtor made all royalty payments required under the Patent Purchase Agreement through the middle of 2001. 4 On August 16, 2001, BDJV sent a Notice of Breach and Intent to Terminate (the “Notice”) to the Debtor due to the Debtor’s failure to pay a portion of the minimum royalty due under section 6(b) for the second quarter of 2001 in the amount of $37,564.11, and the third quarter of 2001 in the amount of $112,692.31 for a total due of $150,256.42. The Notice advised the Debtor that it was required to cure the entire arrearage within thirty days, as set forth in section 10(b) of the Patent Purchase Agreement. In a letter dated September 10, 2001, BDJV extended the termination date in the Notice to October 1, 2001.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bogdanov v. Laflamme (In Re LaFlamme)
2008 BNH 017 (D. New Hampshire, 2008)
Dalton Hydro LLC v. Town of Dalton
889 A.2d 24 (Supreme Court of New Hampshire, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
2003 BNH 13, 296 B.R. 283, 51 U.C.C. Rep. Serv. 2d (West) 274, 2003 Bankr. LEXIS 652, 2003 WL 21474218, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pasteurized-eggs-corp-v-bon-dente-joint-venture-in-re-pasteurized-eggs-nhb-2003.